Important Information for Geron Corporation Investors: Deadline Reminder for Securities Class Action Lawsuit
New York, NY – Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024, and February 25, 2025, both dates inclusive (the “Class Period”), of the upcoming important deadline in the securities class action lawsuit.
What Happened?
Geron Corporation is a biotechnology company focused on developing therapies for aging and age-related diseases. During the Class Period, Geron issued materially false and misleading statements regarding its financial condition and business prospects. The Company’s financial statements were not prepared in accordance with Generally Accepted Accounting Principles (“GAAP”).
On February 26, 2025, Geron announced that it would delay its annual report on Form 10-K for the fiscal year ended December 31, 2024. Following this news, the price of Geron’s securities significantly declined.
Who is Affected?
If you purchased Geron securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lead plaintiff deadline is May 12, 2025.
How Will This Affect Me?
As an individual investor, if you purchased Geron securities during the Class Period, you may have lost significant value in your investment. The securities class action lawsuit allows you to recover your losses through a contingency fee arrangement, meaning you don’t pay any upfront costs or fees.
How Will This Affect the World?
The securities class action lawsuit against Geron Corporation sends a clear message to publicly traded companies about the importance of accurate financial reporting. Geron’s misrepresentations led to significant losses for shareholders, and the lawsuit aims to hold the Company accountable for its actions.
Additionally, this lawsuit may encourage other investors to come forward with information or evidence related to Geron’s financial misstatements. The collective efforts of the securities class action lawsuit and the investigation by regulatory authorities can help restore confidence in the financial markets and protect investors.
Conclusion
If you purchased Geron Corporation securities during the Class Period and believe you may have lost significant value as a result of the Company’s financial misstatements, you have until May 12, 2025, to seek compensation. Contact Rosen Law Firm for more information about the securities class action lawsuit and how you can participate.
- Geron Corporation (NASDAQ: GERN)
- Class Period: February 28, 2024 – February 25, 2025
- Lead Plaintiff Deadline: May 12, 2025
- Contact Rosen Law Firm for more information
